Experts issue recommendations for gender-affirmation treatment for transgender individuals

September 13, 2017, The Endocrine Society

The Endocrine Society today issued a Clinical Practice Guideline on the treatment for gender-dysphoric/gender-incongruent people, commonly referred to as transgender, to develop the physical characteristics of the affirmed gender.

The guideline, entitled "Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline," was published online and will appear in the November 2017 print issue of the Journal of Clinical Endocrinology & Metabolism (JCEM), a publication of the Endocrine Society.

Over the last few decades, there has been a rapid expansion in the understanding of gender identity along with the implications for the care of transgender . The new guideline establishes a framework for the appropriate of these individuals and standardizes terminology to be used by healthcare professionals.

Many transgender individuals are prescribed hormone therapy to reduce the distress caused by having a gender identity that is different from the sex assigned at birth. Endocrinologist—specialists who untangle complex symptoms to diagnose, treat, research or cure hormone-related conditions—play a key role in treating transgender individuals, but a broader healthcare team is needed to provide services and other treatments, such as gender-affirmation surgery.

"Diagnosing clinicians, for adolescents, and mental health professionals for adults all should be knowledgeable about the diagnostic criteria for gender-affirming treatment, have sufficient training and experience in assessing related , and be willing to participate in the ongoing care throughout the endocrine transition," said Wylie Hembree, MD, of the College of Physicians and Surgeons at Columbia University and chair of the task force that authored the guideline.

The Endocrine Society recommends gender-dysphoric/gender-incongruent persons receive a safe and effective hormone regimen that will suppress the body's sex hormone secretion, determined at birth and manifested at puberty, and maintain levels of sex steroids within the normal range for the person's affirmed gender.

Other recommendations from the guideline include:

  • Hormone treatment is not recommended for pre-pubertal gender-dysphoric /gender-incongruent persons;
  • For the care of youths during puberty and older adolescents, an expert multi-disciplinary team comprised of medical professionals and should manage treatment;
  • For adult gender-dysphoric/gender-incongruent persons, the treating clinicians (collectively) should have expertise in transgender-specific diagnostic criteria, mental health, primary care, hormone treatment, and surgery, as needed by the patient;
  • All individuals seeking gender-affirming medical treatment should receive information and counsel on options for fertility preservation prior to initiating puberty suppression in adolescents and prior to treating with hormonal therapy in both adolescents and adults;
  • Removal of gonads may be considered when high doses of sex steroids are required to suppress the body's secretion of hormones, and/or to reduce steroid levels in advanced age; and
  • During sex steroid treatment, clinicians should monitor, in both transgender males (female to male) and/or transgender females (male to female), prolactin, metabolic disorders, and bone loss, as well as cancer risks in individuals who have not undergone surgical treatment.

Because many barriers to improving the health and well-being of transgender patients remain, the Endocrine Society issued a position statement today that calls on federal and private insurers to cover medical interventions for transgender individuals as prescribed by a physician.

The position statement highlights a durable biological underpinning to that should be considered in policy determinations and furthermore calls for increased funding for national research programs to close the gaps in knowledge regarding medical care.

Explore further: AMA joins brief seeking VA coverage of sex reassignment Sx

More information: Wylie C Hembree et al, Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline, The Journal of Clinical Endocrinology & Metabolism (2017). DOI: 10.1210/jc.2017-01658

Related Stories

AMA joins brief seeking VA coverage of sex reassignment Sx

September 10, 2017
(HealthDay)—Several health care-related organizations have filed an amicus brief in support of veterans seeking a rule change that would amend or repeal the U.S. Department of Veterans Affairs (VA) policy of not covering ...

Transgender patients not electing as much gender-affirming surgery as many believe, study finds

May 4, 2017
Researchers from Boston Medical Center (BMC) have conducted the first study in the U.S. to determine the prevalence of gender affirming surgeries among a defined group of transgender patients, and found that most patients ...

Endocrinologists want training in transgender care

January 10, 2017
Four out of five physicians who specialize in treating hormone health conditions have never received formal training on care for transgender individuals, according to a new study published in the Endocrine Society's Journal ...

Many transgender individuals consider their fertility important, survey shows

April 2, 2017
Nearly one-fourth of transgender individuals in Toronto, Canada, regard their own fertility as important, but most lack knowledge regarding and access to reproductive options, a new survey finds. Results of the survey will ...

Study finds hormone therapy in transgender adults safe

February 24, 2015
In the most comprehensive review to date addressing the relative safety of hormone therapy for transgender persons, researchers from Boston University School of Medicine (BUSM) have found that hormone therapy in transgender ...

Review article provides evidence on the biological nature of gender identity

February 13, 2015
Medical care of transgender patients, including surgical and hormonal treatment, has largely been met with resistance by physicians in favor of psychiatric treatment, owing to misconceptions that gender identity can be changed. ...

Recommended for you

Americans are getting more sleep

January 19, 2018
Although more than one in three Americans still don't get enough sleep, a new analysis shows first signs of success in the fight for more shut eye. According to data from 181,335 respondents aged 15 and older who participated ...

Wine is good for you—to a point

January 18, 2018
The Mediterranean diet has become synonymous with healthy eating, but there's one thing in it that stands out: It's cool to drink wine.

Sleep better, lose weight?

January 17, 2018
(HealthDay)—Sleeplessness could cost you when it's time to stand on your bathroom scale, a new British study suggests.

Who uses phone apps to track sleep habits? Mostly the healthy and wealthy in US

January 16, 2018
The profile of most Americans who use popular mobile phone apps that track sleep habits is that they are relatively affluent, claim to eat well, and say they are in good health, even if some of them tend to smoke.

Improvements in mortality rates are slowed by rise in obesity in the United States

January 15, 2018
With countless medical advances and efforts to curb smoking, one might expect that life expectancy in the United States would improve. Yet according to recent studies, there's been a reduction in the rate of improvement in ...

Can muesli help against arthritis?

January 15, 2018
It is well known that healthy eating increases a general sense of wellbeing. Researchers at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) have now discovered that a fibre-rich diet can have a positive influence ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.